- Home
- EBS vs HRZN Comparison
EBS vs HRZN Comparison
Compare EBS & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- HRZN
- Stock Information
- Founded
- EBS 1998
- HRZN 2008
- Country
- EBS United States
- HRZN United States
- Employees
- EBS N/A
- HRZN N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- HRZN Finance/Investors Services
- Sector
- EBS Health Care
- HRZN Finance
- Exchange
- EBS Nasdaq
- HRZN Nasdaq
- Market Cap
- EBS 393.9M
- HRZN 341.0M
- IPO Year
- EBS 2006
- HRZN 2010
- Fundamental
- Price
- EBS $5.04
- HRZN $8.48
- Analyst Decision
- EBS Strong Buy
- HRZN Hold
- Analyst Count
- EBS 3
- HRZN 5
- Target Price
- EBS $14.33
- HRZN $9.20
- AVG Volume (30 Days)
- EBS 1.2M
- HRZN 410.1K
- Earning Date
- EBS 05-07-2025
- HRZN 04-29-2025
- Dividend Yield
- EBS N/A
- HRZN 15.87%
- EPS Growth
- EBS N/A
- HRZN N/A
- EPS
- EBS N/A
- HRZN N/A
- Revenue
- EBS $1,043,600,000.00
- HRZN $99,915,000.00
- Revenue This Year
- EBS N/A
- HRZN $12.95
- Revenue Next Year
- EBS $19.88
- HRZN $8.81
- P/E Ratio
- EBS N/A
- HRZN N/A
- Revenue Growth
- EBS N/A
- HRZN N/A
- 52 Week Low
- EBS $1.82
- HRZN $7.55
- 52 Week High
- EBS $15.10
- HRZN $12.63
- Technical
- Relative Strength Index (RSI)
- EBS 48.72
- HRZN 45.17
- Support Level
- EBS $4.13
- HRZN $8.04
- Resistance Level
- EBS $4.69
- HRZN $8.40
- Average True Range (ATR)
- EBS 0.35
- HRZN 0.41
- MACD
- EBS 0.15
- HRZN 0.01
- Stochastic Oscillator
- EBS 94.91
- HRZN 51.70
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services and sustainability industries.